Advances in Pulmonary Hypertension | |
Review of Latest Publications: Reviews of the Latest Published Research | |
1  | |
关键词: Cardiology; Rheumatology; WHO Group 1- Pulmonary Arterial Hypertension; PH Medications; Gender; PH; Associated Diseases; Systolic dysfunction; Oral therapy; IV therapy; Subcutaneous therapy; Inhaled therapy; Phosphodiesterase Inhibitors (PDE-5 Inhibitors); Prostacyclin; Endothelin Receptor Antagonists; pharmacokinetics; Cardiac Index; Fick; Thermodilution; endothelial dysfunction; tricuspid regurgitation; Functional Class; clinical trial; clinical trial endpoints; REVEAL; Epidemiology; | |
DOI : | |
学科分类:医学(综合) | |
来源: Pulmonary Hypertension Association | |
【 摘 要 】
This study reports the observed survival of patients with idiopathic, familial (heritable), and anorexigen-associated pulmonary arterial hypertension (PAH) from the French Network on Pulmonary Hypertension. This registry draws from 17 pulmonary vascular centers in France. A total of 354 consecutive patients (56 incident, 298 prevalent) were enrolled from October 2002 to October 2003, and followed prospectively. Of the prevalent cases, only those with diagnosis less than 36 months from the time of enrollment were included in the survival analysis. The final cohort of 190 patients was followed for 3 years.
【 授权许可】
All Rights reserved
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201902195340895ZK.pdf | 75KB | download |